<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03907007</url>
  </required_header>
  <id_info>
    <org_study_id>Par-03</org_study_id>
    <nct_id>NCT03907007</nct_id>
  </id_info>
  <brief_title>Effect of Auricular Stimulation on Locomotion in Patients With Parkinson's Disease</brief_title>
  <official_title>Effect of Auricular Stimulation on Locomotion in Patients With Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inventram</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ko√ß University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Inventram</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of auricular stimulation on the locomotion capability in patients with Parkinson's
      Disease was investigated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Effect of the auricular stimulation as a supplementary and alternative usage to Levodopa was
      investigated in this study. Clinical data were collected through motion capture system while
      the participants performed the clinical task asked by the investigators.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Actual">May 1, 2018</completion_date>
  <primary_completion_date type="Actual">May 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stride length [m]</measure>
    <time_frame>Time Frame: Baseline</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stride length [m]</measure>
    <time_frame>Time Frame: 20 minutes after stimulation is initiated</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stride length [m]</measure>
    <time_frame>Time Frame: 40 minutes after stimulation is initiated</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stride length [m]</measure>
    <time_frame>Time Frame: 60 minutes after stimulation is initiated</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stride velocity [m/s]</measure>
    <time_frame>Time Frame: Baseline</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stride velocity [m/s]</measure>
    <time_frame>Time Frame: 20 minutes after stimulation is initiated</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stride velocity [m/s]</measure>
    <time_frame>Time Frame: 40 minutes after stimulation is initiated</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stride velocity [m/s]</measure>
    <time_frame>Time Frame: 60 minutes after stimulation is initiated</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Turning Velocity [deg/s]</measure>
    <time_frame>Time Frame: Baseline</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Turning Velocity [deg/s]</measure>
    <time_frame>Time Frame: 20 minutes after stimulation is initiated</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Turning Velocity [deg/s]</measure>
    <time_frame>Time Frame: 40 minutes after stimulation is initiated</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Turning Velocity [deg/s]</measure>
    <time_frame>Time Frame: 60 minutes after stimulation is initiated</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Double Support Percentage during walking [%]</measure>
    <time_frame>Time Frame: Baseline, 20 minutes, 40 minutes, 60 minutes</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Double Support Percentage during walking [%]</measure>
    <time_frame>Time Frame: 20 minutes after stimulation is initiated</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Double Support Percentage during walking [%]</measure>
    <time_frame>Time Frame: 40 minutes after stimulation is initiated</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Double Support Percentage during walking [%]</measure>
    <time_frame>Time Frame: 60 minutes after stimulation is initiated</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Swing Phase Percentage during walking [%]</measure>
    <time_frame>Time Frame: Baseline</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Swing Phase Percentage during walking [%]</measure>
    <time_frame>Time Frame: 20 minutes after stimulation is initiated</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Swing Phase Percentage during walking [%]</measure>
    <time_frame>Time Frame: 40 minutes after stimulation is initiated</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Swing Phase Percentage during walking [%]</measure>
    <time_frame>Time Frame: 60 minutes after stimulation is initiated</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stance Phase Percentage during walking [%]</measure>
    <time_frame>Time Frame: Baseline, 20 minutes, 40 minutes, 60 minutes</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stance Phase Percentage during walking [%]</measure>
    <time_frame>Time Frame: 20 minutes after stimulation is initiated</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stance Phase Percentage during walking [%]</measure>
    <time_frame>Time Frame: 40 minutes after stimulation is initiated</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stance Phase Percentage during walking [%]</measure>
    <time_frame>Time Frame: 60 minutes after stimulation is initiated</time_frame>
    <description>Measurement through motion capture system</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Sole Medication</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Monitoring under current prescribed medication</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combined stimulation &amp; medication</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Concurrent usage of stimulation with the prescribed medication</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sole Stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Alternating usage of stimulation to the prescribed medication</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Percutaneous electrical nerve stimulation</intervention_name>
    <description>Stimulation and medication at the same instant</description>
    <arm_group_label>Combined stimulation &amp; medication</arm_group_label>
    <other_name>Stimulation &amp; Medication</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Percutaneous electrical nerve stimulation</intervention_name>
    <description>Stimulation is given without administering medication</description>
    <arm_group_label>Sole Stimulation</arm_group_label>
    <other_name>Stimulation Only</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of Parkinson's Disease

          -  H&amp;Y Stage &gt;= 1

          -  Existing bradykinesia symptoms

          -  Existence of one of the symptoms below

          -  Resting Tremor

          -  Rigidity

          -  Walking disorder

        Exclusion Criteria:

          -  Cardiac Pacemaker

          -  Psychiatric diagnosis

          -  Irregular heart/respiration rate

          -  Pregnancy

          -  Alcohol consumption

          -  Cardiovascular disease history

          -  Wearing an electro-active prosthesis

          -  Brain surgery history

          -  Ongoing TENS/PENS therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yusuf O Cakmak, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Otago University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Koc University Hospital</name>
      <address>
        <city>ƒ∞stanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 29, 2019</study_first_submitted>
  <study_first_submitted_qc>April 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2019</study_first_posted>
  <last_update_submitted>March 9, 2020</last_update_submitted>
  <last_update_submitted_qc>March 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neurostimulator</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

